HOSPITAL UNIVERSITARIO INFANTA SOFÍA
Departamento
Instituto Valenciano de Oncologia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Instituto Valenciano de Oncologia (2)
2012
-
Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target
International Journal of Radiation Oncology Biology Physics, Vol. 84, Núm. 5, pp. 1151-1158
2011
-
A combined strategy of SAGE and quantitative PCR provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer
Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4145-4154